|
Praxis Precision Medicines, Inc. (PRAX) Valoración de DCF
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Praxis Precision Medicines, Inc. (PRAX) Bundle
Ingementada para su precisión, nuestra calculadora DCF (PRAX) le permite evaluar la valoración de Praxis Precision Medicines, Inc. utilizando datos financieros del mundo real al tiempo que ofrece flexibilidad completa para modificar todos los parámetros esenciales para las proyecciones mejoradas.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | 2.4 | 8.6 | 10.7 | 13.4 | 16.7 | 20.9 | 26.1 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 249.53 | 25 | 25 | 25 | 25 | 25 |
| EBITDA | -61.1 | -165.5 | -212.9 | -125.9 | -200.2 | 2.1 | 2.7 | 3.3 | 4.2 | 5.2 |
| EBITDA, % | 100 | 100 | 100 | -5146.75 | -2340.29 | 20 | 20 | 20 | 20 | 20 |
| Depreciation | .7 | 1.6 | 1.2 | .4 | .0 | 6.8 | 8.5 | 10.6 | 13.3 | 16.6 |
| Depreciation, % | 100 | 100 | 100 | 17.65 | 0 | 63.53 | 63.53 | 63.53 | 63.53 | 63.53 |
| EBIT | -61.8 | -167.1 | -214.0 | -126.4 | -200.2 | 2.1 | 2.7 | 3.3 | 4.2 | 5.2 |
| EBIT, % | 100 | 100 | 100 | -5164.41 | -2340.29 | 20 | 20 | 20 | 20 | 20 |
| Total Cash | 296.6 | 275.9 | 100.5 | 81.3 | 392.6 | 10.7 | 13.4 | 16.7 | 20.9 | 26.1 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | 6.4 | 8.0 | 10.0 | 12.5 | 15.7 |
| Account Receivables, % | 100 | 100 | 100 | 0 | 0 | 60 | 60 | 60 | 60 | 60 |
| Inventories | .0 | .0 | .0 | .0 | .0 | 6.4 | 8.0 | 10.0 | 12.5 | 15.7 |
| Inventories, % | 100 | 100 | 100 | 0 | 0 | 60 | 60 | 60 | 60 | 60 |
| Accounts Payable | 4.1 | 10.8 | 14.7 | 5.8 | 12.5 | 10.7 | 13.4 | 16.7 | 20.9 | 26.1 |
| Accounts Payable, % | 100 | 100 | 100 | 237.64 | 146.47 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | .0 | -1.1 | -.4 | -.1 | .0 | .0 | -.1 | -.1 | -.1 | -.1 |
| Capital Expenditure, % | 100 | 100 | 100 | -2.04 | 0 | -0.40866 | -0.40866 | -0.40866 | -0.40866 | -0.40866 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -61.8 | -166.9 | -213.1 | -126.4 | -200.2 | 2.1 | 2.7 | 3.3 | 4.2 | 5.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -57.0 | -159.6 | -208.5 | -134.8 | -193.5 | -5.8 | 10.6 | 13.2 | 16.5 | 20.6 |
| WACC, % | 16.6 | 16.6 | 16.6 | 16.6 | 16.6 | 16.6 | 16.6 | 16.6 | 16.6 | 16.6 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 29.7 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 21 | |||||||||
| Terminal Value | 144 | |||||||||
| Present Terminal Value | 67 | |||||||||
| Enterprise Value | 97 | |||||||||
| Net Debt | -214 | |||||||||
| Equity Value | 311 | |||||||||
| Diluted Shares Outstanding, MM | 18 | |||||||||
| Equity Value Per Share | 17.35 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real PRAX financials.
- Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe how your inputs affect Praxis Precision Medicines’ valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- 🔍 Real-Life PRAX Financials: Pre-filled historical and projected data for Praxis Precision Medicines, Inc.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Praxis's intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Praxis's valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Download the Template: Gain immediate access to the Excel-based PRAX DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional variables.
- Instant Calculations: The model automatically recalculates the intrinsic value of Praxis Precision Medicines.
- Test Scenarios: Explore various assumptions to assess potential valuation shifts.
- Analyze and Decide: Leverage the results to inform your investment or financial strategy.
Why Choose This Calculator for Praxis Precision Medicines, Inc. (PRAX)?
- Accuracy: Utilizes real Praxis financial data to guarantee precise calculations.
- Flexibility: Allows users to easily adjust and experiment with various inputs.
- Time-Saving: Eliminates the need to construct a financial model from the ground up.
- Professional-Grade: Crafted with the expertise and attention to detail expected at the CFO level.
- User-Friendly: Intuitive design makes it accessible for users without extensive financial modeling skills.
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling Praxis Precision Medicines, Inc. (PRAX) stock.
- Financial Analysts: Streamline valuation processes with ready-to-use financial models for Praxis Precision Medicines, Inc. (PRAX).
- Consultants: Deliver professional valuation insights on Praxis Precision Medicines, Inc. (PRAX) to clients quickly and accurately.
- Business Owners: Understand how biotech companies like Praxis Precision Medicines, Inc. (PRAX) are valued to guide your own strategy.
- Finance Students: Learn valuation techniques using real-world data and scenarios related to Praxis Precision Medicines, Inc. (PRAX).
What the Template Contains
- Historical Data: Includes Praxis Precision Medicines’ past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Praxis Precision Medicines’ intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Praxis Precision Medicines’ financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.